NIH studies found severe symptoms of ‘Havana Syndrome,’ but no evidence of brain injury or abnormalities
On Mar. 18, 2024, using advanced imaging techniques and in-depth clinical assessments, a research team at the National…
-
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
NIH researchers identified brain connections associated with ADHD in youth
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
-
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
-
Biotechnology | Clinical Research | Disease | Medicine | Neurology | Oncology | Stem Cell | Therapeutics
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
-
Gene study identifies DNA variants linked to dyslexia
On Jan. 25, 2024, a study led by the University of Edinburgh, is the largest genetic study of…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Neurology | Therapeutics
Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
-
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
-
Artificial Intelligence | Biotechnology | Imaging | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Therapeutics
University of Michigan Center for Innovation breaks ground
On Dec. 14, 2023, the University of Michigan Center for Innovation (UMCI) in Detroit broke ground with high-energy…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
PNNL created Center for Artificial Intelligence
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
-
Allen Institute scientists and partners unveiled first complete cellular map of adult mouse brain
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
-
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
-
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
-
University of Wisconsin-Madison discovery revealed fragile X syndrome begins developing even before birth
On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…
-
California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
-
USDA provided more than $12 million in funding to control and prevent chronic wasting disease
On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
-
Newly discovered trigger of Parkinson’s upends common beliefs
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration…
-
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
-
U.S. FDA approved ZURZUVAE (zuranolone), the First and only oral treatment for Women with postpartum depression
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
-
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthﾒs…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted traditional approval for LEQEMBI (lecanemab-irmb) for the treatment of Alzheimer’s disease
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
Donald Triplett, the 1st person diagnosed with autism, died at 89
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
-
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
-
NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
-
Parkinson’s disease biomarker found
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
-
FDA approved first treatment for Rett syndrome
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…
-
Abbott received FDA clearance for first commercially available lab-based blood test to help evaluate concussion
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
-
FDA grants Lenire Tinnitus treatment device de novo approval
On Mar. 6, 2023, Neuromod Devices announced that the U.S. Food and Drug Administration (FDA) had granted De…
